The Latest Breaking News from FDA

Companies can speak up, engage with lawmakers, and communicate to their workforces.

Labour says data reveals ‘mental health crisis at the heart of Whitehall’, as unions blame staff cuts, low pay and long hours

A federal judge's 67-page decision to roll back FDA approval of mifepristone repeatedly borrowed terms from antiabortion advocates.

Xavier Becerra suggested White House would be willing to ignore Texas court ruling

WASHINGTON — The Biden administration is weighing every option to strike down a “reckless” ruling by a federal judge in Texas that suspended U.S. approval of a key drug used in medication abortions, Xavier Becerra, the secretary of Health and Human Services, said on Sunday.

The nation’s top health official says a court ruling threatening the availability of a main drug used in medication abortion was “not America.”

Democratic New York congresswoman says there is ‘extraordinary precedent’ for Biden to decline to enforce ruling

A simple blood test could detect a multitude of potential cancers. It could also open a Pandora's box, unveiling problems science isn't ready to tackle.

A Republican-appointed federal judge in Texas issued an order suspending the US government’s decades-old approval of a key drug used in medication abortion, initiating a process that could block access to the pill nationwide in a week.

Democrats including Senate majority leader warn of ‘dangerous new precedent’ set by ruling and vow to fight it

A 19th century “anti-vice” law is at the center of a new court ruling that threatens access to the leading abortion drug in the U.S. Dormant for a half-century, the Comstock Act is being been revived by groups seeking to block the mailing of mifepristone, the pill used in more…